Agilent lifts outlook after Q2, shares hold above consensus

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-27, 10:21.

Agilent Technologies (US00846U1016) has a new analyst backdrop on NYSE trade. Bernstein SocGen resumed coverage with an Outperform rating and a $155 target, according to Investing.com on Thursday.

Bernstein sets the tone

Investing.com reported that Bernstein SocGen resumed coverage on Agilent Technologies Inc. with an Outperform rating and a $155 price target. The same report said the stock traded at $135.51 at the time, which left the target implying about 14% upside.

MarketBeat’s earnings page adds the hard numbers from the latest report. Agilent released Q2 fiscal 2026 earnings on May 27, 2026, and reported EPS of $1.49, above the $1.41 consensus estimate cited there.

Consensus still looks firm

Pricetargets.com shows a Moderate Buy consensus for Agilent with 18 analysts in the sample. Its page lists 14 Buy ratings, three Hold ratings and one Strong Buy rating, with a consensus target of $160.88.

That backdrop matters on a Saturday session, because the shares already closed the prior session at $136.29 on NYSE trade. Nasdaq’s post-earnings note said the company also lifted its fiscal 2026 outlook after the Q2 print.

The business behind the stock

Agilent’s core business spans analytical instruments, diagnostics and laboratory services. Its portfolio includes chromatography, mass spectrometry and life-science testing systems for research and applied markets.

NYSE price at the close

The Agilent Technologies shares (US00846U1016) trade on 2026-06-26, 15:59 on NYSE at $136.29.

This article is for information only and does not constitute investment advice.